RxDoctor Payments Data

My Thuong Quirino, PA

Medical · Mesa, AZNPI 1245859115

Payments from drug & device makers

$159in general payments, 2019–2025

Across 9 payments — averaging $17.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$35
  • Astellas Pharma US Inc$21
  • Boston Scientific$19
  • Amgen$19
  • Otsuka America Pharmaceutical, Inc.$18
  • Merck$16
  • plus $29 from 2 others

What the payments were for

  • Food & beverage$159100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$159 in reported general payments places this provider in the 30th percentile of 748 medical providers in Arizona.

See all medical providers in Arizona

Medicare billing

Part B allowed, 2024
$75,584
Medicare patients
270
Services billed
1,346

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide70$117,122
EliquisApixaban44$54,459
BiktarvyBictegrav/Emtricit/Tenofov Ala13$49,519
Trelegy ElliptaFluticasone/Umeclidin/Vilanter25$28,596
JanuviaSitagliptin Phosphate24$16,523
MyrbetriqMirabegron15$15,554
Xtampza ErOxycodone Myristate14$14,723
TrulicityDulaglutide12$13,865
InvokanaCanagliflozin14$8,052
Lantus SolostarInsulin Glargine,hum.Rec.Anlog36$6,538
Rufinamide11$6,001
SymbicortBudesonide/Formoterol Fumarate11$2,629
Fluticasone-SalmeterolFluticasone Propion/Salmeterol12$2,476
Novolog FlexpenInsulin Aspart15$2,123
Gabapentin79$2,095

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta$15$28,59625 claims
MerckJanuvia$16$16,52324 claims
Astellas Pharma US IncMyrbetriq$21$15,55415 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 30th percentile of 748 medical providers in Arizona.

Other medical in Mesa

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →